Your browser doesn't support javascript.
loading
PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques.
Kauffman, Keith D; Sakai, Shunsuke; Lora, Nickiana E; Namasivayam, Sivaranjani; Baker, Paul J; Kamenyeva, Olena; Foreman, Taylor W; Nelson, Christine E; Oliveira-de-Souza, Deivide; Vinhaes, Caian L; Yaniv, Ziv; Lindestam Arleham, Cecilia S; Sette, Alessandro; Freeman, Gordon J; Moore, Rashida; Sher, Alan; Mayer-Barber, Katrin D; Andrade, Bruno B; Kabat, Juraj; Via, Laura E; Barber, Daniel L.
Afiliação
  • Kauffman KD; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Sakai S; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Lora NE; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Namasivayam S; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Baker PJ; Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Kamenyeva O; Biological Imaging Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Foreman TW; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Nelson CE; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Oliveira-de-Souza D; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Intituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
  • Vinhaes CL; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Intituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
  • Yaniv Z; Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Lindestam Arleham CS; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Sette A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Freeman GJ; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Moore R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Mayer-Barber KD; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Andrade BB; Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Kabat J; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Intituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
  • Via LE; Biological Imaging Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Barber DL; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Sci Immunol ; 6(55)2021 01 15.
Article em En | MEDLINE | ID: mdl-33452107

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Linfócitos T CD4-Positivos / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Sci Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Linfócitos T CD4-Positivos / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Sci Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos